Skip to content
10-Q

Quarterly Report

PROTECT PHARMACEUTICAL Corp

0001493152-19-002930

← back to feed
Filed
Mar 6, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2018 · Jun 30, 2018 1.36M sh
Shares Diluted Q2 2018 · Jun 30, 2018 1.36M sh
Shares Diluted Q2 2018 · Jun 30, 2017 1.11M sh
Shares Diluted Q2 2018 · Jun 30, 2017 1.11M sh
Shares Outstanding Q2 2018 · Jun 30, 2018 1.11M sh
Operating Cash Flow Q2 2018 · Jun 30, 2018 $72
Cash And Equivalents Q2 2018 · Jun 30, 2018 $20.07K
Stockholders Equity Q2 2018 · Jun 30, 2018 −$151.6K
Stockholders Equity Q2 2018 · Dec 31, 2017 −$143.44K
Current Liabilities Q2 2018 · Jun 30, 2018 $50.67K
Current Liabilities Q2 2018 · Dec 31, 2017 $42.44K
Total Liabilities Q2 2018 · Jun 30, 2018 $171.67K
Total Liabilities Q2 2018 · Dec 31, 2017 $143.44K
Current Assets Q2 2018 · Jun 30, 2018 $20.07K
Total Assets Q2 2018 · Jun 30, 2018 $20.07K
Total Assets Q2 2018 · Dec 31, 2017 $0
Eps Diluted Q2 2018 · Jun 30, 2018 $0.00
Eps Diluted Q2 2018 · Jun 30, 2018 −$0.01
Eps Diluted Q2 2018 · Jun 30, 2017 −$0.09
Eps Diluted Q2 2018 · Jun 30, 2017 −$0.10
Sga Expense Q2 2018 · Jun 30, 2018 $707
Sga Expense Q2 2018 · Jun 30, 2018 $707
Sga Expense Q2 2018 · Jun 30, 2017 $200
Net Income Q2 2018 · Jun 30, 2018 −$4.43K
Net Income Q2 2018 · Jun 30, 2018 −$8.16K
Net Income Q2 2018 · Jun 30, 2017 −$100.33K
Net Income Q2 2018 · Jun 30, 2017 −$115.73K
Operating Income Q2 2018 · Jun 30, 2018 −$707
Operating Income Q2 2018 · Jun 30, 2018 −$707
Operating Income Q2 2018 · Jun 30, 2017 −$100K
Operating Income Q2 2018 · Jun 30, 2017 −$115.4K